TrialEuropean heart journal2022

Five-year outcomes after state-of-the-art percutaneous coronary revascularization in patients with de novo three-vessel disease: final results of the SYNTAX II study.

Adrian P Banning et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.